Editorial: The relevance of biologics for the treatment of patients with psoriasis

British Journal of Dermatology

Volumn 161, Issue 6, 2009, Pages 1213-1214

  Van De Kerkhof, Peter C M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; CORTICOSTEROID; CYCLOSPORIN; DITHRANOL; EFALIZUMAB; ETANERCEPT; ETRETIN; FUMARIC ACID DERIVATIVE; INFLIXIMAB; METHOTREXATE; TAR; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; USTEKINUMAB; VITAMIN D; BIOLOGICAL PRODUCT;

CORTICOSTEROID THERAPY; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; EDITORIAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LONG TERM CARE; PATIENT SATISFACTION; PHOTOTHERAPY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSORIASIS; UNITED KINGDOM;

BIOLOGICAL PRODUCTS; GREAT BRITAIN; HUMANS; PRACTICE GUIDELINES AS TOPIC; PSORIASIS;

EID: 72649084528     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2009.09499.x     Document Type: Editorial

References (9)

1. Smith CH, Anstey AV, Barker JNWN et al. British Association of Dermatologists' guidelines for biologic interventions for psoriasis 2009. Br J Dermatol 2009 161 : 987 1019.
2. Christophers E, Griffiths CEM, Gaitanis G, van de Kerkhof P. The unmet treatment need for moderate to severe psoriasis: results of a survey and chart review. J Eur Acad Dermatol Venereol 2006 20 : 921 925.
3. Patel V, Horn EJ, Lobosco SJ et al. Psoriasis treatment patterns: results of a cross-sectional survey of dermatologists. J Am Acad Dermatol 2008 58 : 964 969.
4. Swinkels OQ, Prins M, Veenhuis RT et al. Effectiveness and side effects of UVB-phototherapy, dithranol inpatient therapy and a care instruction programme of short contact dithranol in moderate to severe psoriasis. Eur J Dermatol 2004 14 : 15 65.
5. Dubertret L, Mrowietz U, Ranki A et al. European patient perspectives on the impact of psoriasis: the EUROPSO patient membership survey. Br J Dermatol 2006 155 : 729 736.
6. Gottlieb AB, Chaudhari U, Mulcahy LD et al. Infliximab monotherapy provides rapid and sustained benefit for plaque-type psoriasis. J Am Acad Dermatol 2003 48 : 829 835.
7. Driessen RJB, de Jong EMGJ, de Rie MA et al. Analysis of 3-year national reimbursement application data on etanercept and efalizumab for psoriasis. Br J Dermatol 2008 159 : 733 772.
8. Sterry W, Barker J, Boehncke WH et al. Biological therapies in the systemic management of psoriasis: International Consensus Conference. Br J Dermatol 2004 151 (Suppl. 69 3 17.
9. Eedy DJ, Griffiths CE, Chalmers RJ et al. Care of patients with psoriasis: an audit of U.K. services in secondary care. Br J Dermatol 2009 160 : 557 564.